Published Date：Nov. 2020
Industry：Medical Devices & Consumables
Pages：114 Table Number：134
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Drug-Eluting Bioabsorbable Stents market in this environment. In terms of revenue, this research report indicated that the global Drug-Eluting Bioabsorbable Stents market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Drug-Eluting Bioabsorbable Stents industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The ??Medtronic aims at producing XX Drug-Eluting Bioabsorbable Stents in 2020, with XX % production to take place in global market, ????B.Braun Melsungen accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Drug-Eluting Bioabsorbable Stents Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Drug-Eluting Bioabsorbable Stents Market? Medtronic B.Braun Melsungen Abbott Laboratories Boston Scientific Corporation Biosensors International Terumo Corporation. MicroPort Scientific Corporation Alvimedica Biotronik Elixir Medical Corporation Innovative Health Technologies ... Major Type of Drug-Eluting Bioabsorbable Stents Covered in XYZResearch report: Serolimus and Paclitaxel Drug-Eluting Stents Sirolimus Drug Eluting Stents Application Segments Covered in XYZResearch Market Coronary Artery Diseases Peripheral Artery Diseases Application 3 For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Drug-Eluting Bioabsorbable Stents Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Serolimus and Paclitaxel Drug-Eluting Stents -Product Introduction and Major Manufacturers 1.1.2 Sirolimus Drug Eluting Stents -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Drug-Eluting Bioabsorbable Stents Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Drug-Eluting Bioabsorbable Stents Market 3.1.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Drug-Eluting Bioabsorbable Stents Market 3.2.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Drug-Eluting Bioabsorbable Stents Market 3.3.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Drug-Eluting Bioabsorbable Stents Market 3.4.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Drug-Eluting Bioabsorbable Stents Market 3.5.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Drug-Eluting Bioabsorbable Stents Market 3.6.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Drug-Eluting Bioabsorbable Stents Market 3.7.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Drug-Eluting Bioabsorbable Stents Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Drug-Eluting Bioabsorbable Stents Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2021-2026) 5.2 Global Drug-Eluting Bioabsorbable Stents Sales Value and Growth Rate (2021-2026) 6 Drug-Eluting Bioabsorbable Stents Competitive Analysis 6.1 Medtronic 6.1.1 Medtronic Company Profiles 6.1.2 Medtronic Product Introduction 6.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 B.Braun Melsungen 6.2.1 B.Braun Melsungen Company Profiles 6.2.2 B.Braun Melsungen Product Introduction 6.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Abbott Laboratories 6.3.1 Abbott Laboratories Company Profiles 6.3.2 Abbott Laboratories Product Introduction 6.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Boston Scientific Corporation 6.4.1 Boston Scientific Corporation Company Profiles 6.4.2 Boston Scientific Corporation Product Introduction 6.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Biosensors International 6.5.1 Biosensors International Company Profiles 6.5.2 Biosensors International Product Introduction 6.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Terumo Corporation. 6.6.1 Terumo Corporation. Company Profiles 6.6.2 Terumo Corporation. Product Introduction 6.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 MicroPort Scientific Corporation 6.7.1 MicroPort Scientific Corporation Company Profiles 6.7.2 MicroPort Scientific Corporation Product Introduction 6.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 Alvimedica 6.8.1 Alvimedica Company Profiles 6.8.2 Alvimedica Product Introduction 6.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Biotronik 6.9.1 Biotronik Company Profiles 6.9.2 Biotronik Product Introduction 6.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 6.10 Elixir Medical Corporation 6.10.1 Elixir Medical Corporation Company Profiles 6.10.2 Elixir Medical Corporation Product Introduction 6.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020) 6.10.4 SWOT Analysis 6.11 Innovative Health Technologies 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Drug-Eluting Bioabsorbable Stents Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Drug-Eluting Bioabsorbable Stents Sales (K Unit) by Type (2015-2026) Figure Global Drug-Eluting Bioabsorbable Stents Sales (K Unit) and Growth Rate (2015-2026) Figure Global Drug-Eluting Bioabsorbable Stents Sales Market Share (%) by Type (2019 -2020) Table Global Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) by Type (2015-2026) Figure Global Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Drug-Eluting Bioabsorbable Stents Sales Value Market Share (%) by Type (2019-2020) Table Global Drug-Eluting Bioabsorbable Stents Sales (K Unit) by Application (2015-2026) Table China Drug-Eluting Bioabsorbable Stents Sales (K Unit) of Major Company (2015-2020) Table China Drug-Eluting Bioabsorbable Stents Sales Market Share of Major Company (2015-2020) Table China Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) of Major Company (2015-2020) Figure China Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) and Growth Rate (2015-2020) Table China Drug-Eluting Bioabsorbable Stents Sales Value Share of Major Company (2015-2020) Table China Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) Table China Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Figure China Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Table EU Drug-Eluting Bioabsorbable Stents Sales (K Unit) of Major Company (2015-2020) Table EU Drug-Eluting Bioabsorbable Stents Sales Market Share of Major Company (2015-2020) Table EU Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) of Major Company (2015-2020) Figure EU Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Drug-Eluting Bioabsorbable Stents Sales Value Share of Major Company (2015-2020) Table EU Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) Table EU Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Figure EU Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Table USA Drug-Eluting Bioabsorbable Stents Sales (K Unit) of Major Company (2015-2020) Table USA Drug-Eluting Bioabsorbable Stents Sales Market Share of Major Company (2015-2020) Table USA Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) of Major Company (2015-2020) Figure USA Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Drug-Eluting Bioabsorbable Stents Sales Value Share of Major Company (2015-2020) Table USA Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) Table USA Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Figure USA Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Table Japan Drug-Eluting Bioabsorbable Stents Sales (K Unit) of Major Company (2015-2020) Table Japan Drug-Eluting Bioabsorbable Stents Sales Market Share of Major Company (2015-2020) Table Japan Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Drug-Eluting Bioabsorbable Stents Sales Value Share of Major Company (2015-2020) Table Japan Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) Table Japan Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Figure Japan Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Table India Drug-Eluting Bioabsorbable Stents Sales (K Unit) of Major Company (2015-2020) Table India Drug-Eluting Bioabsorbable Stents Sales Market Share of Major Company (2015-2020) Table India Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) of Major Company (2015-2020) Figure India Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) and Growth Rate (2015-2020) Table India Drug-Eluting Bioabsorbable Stents Sales Value Share of Major Company (2015-2020) Table India Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) Table India Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Figure India Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Table Southeast Asia Drug-Eluting Bioabsorbable Stents Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Drug-Eluting Bioabsorbable Stents Sales Market Share of Major Company (2015-2020) Table Southeast Asia Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Drug-Eluting Bioabsorbable Stents Sales Value Share of Major Company (2015-2020) Table Southeast Asia Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Figure Southeast Asia Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Table South America Drug-Eluting Bioabsorbable Stents Sales (K Unit) of Major Company (2015-2020) Table South America Drug-Eluting Bioabsorbable Stents Sales Market Share of Major Company (2015-2020) Table South America Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) of Major Company (2015-2020) Figure South America Drug-Eluting Bioabsorbable Stents Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Drug-Eluting Bioabsorbable Stents Sales Value Share of Major Company (2015-2020) Table South America Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020) Table South America Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Figure South America Drug-Eluting Bioabsorbable Stents Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Drug-Eluting Bioabsorbable Stents Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Drug-Eluting Bioabsorbable Stents Figure Cost Structure of Drug-Eluting Bioabsorbable Stents in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Drug-Eluting Bioabsorbable Stents Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Drug-Eluting Bioabsorbable Stents Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table ??Medtronic Profiles Table ??Medtronic Drug-Eluting Bioabsorbable Stents Product Introduction Table ??Medtronic Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ??Medtronic SWOT Analysis Table ????B.Braun Melsungen Profiles Table ????B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Introduction Table ????B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????B.Braun Melsungen SWOT Analysis Table ????Abbott Laboratories Profiles Table ????Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Introduction Table ????Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Abbott Laboratories SWOT Analysis Table ????Boston Scientific Corporation Profiles Table ????Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Introduction Table ????Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Boston Scientific Corporation SWOT Analysis Table ????Biosensors International Profiles Table ????Biosensors International Drug-Eluting Bioabsorbable Stents Product Introduction Table ????Biosensors International Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Biosensors International SWOT Analysis Table ????Terumo Corporation. Profiles Table ????Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Introduction Table ????Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Terumo Corporation. SWOT Analysis Table ????MicroPort Scientific Corporation Profiles Table ????MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Introduction Table ????MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????MicroPort Scientific Corporation SWOT Analysis Table ????Alvimedica Profiles Table ????Alvimedica Drug-Eluting Bioabsorbable Stents Product Introduction Table ????Alvimedica Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Alvimedica SWOT Analysis Table ????Biotronik Profiles Table ????Biotronik Drug-Eluting Bioabsorbable Stents Product Introduction Table ????Biotronik Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Biotronik SWOT Analysis Table ????Elixir Medical Corporation Profiles Table ????Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Introduction Table ????Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Elixir Medical Corporation SWOT Analysis Table ????Innovative Health Technologies Profiles Table ????Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Introduction Table ????Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
